TG盗号系统企业破解技术|【唯一TG:@heimifeng8】|飞机盗号软件VIP专供✨谷歌搜索留痕排名,史上最强SEO技术,20年谷歌SEO经验大佬✨The FDA warns patients about counterfeit Ozempic that may be in circulation : NPR
The injectable drug Ozempic is shown in Houston on July 1, 2025. David J. Phillip/AP hide caption
toggle caption David J. Phillip/APThe Food and Drug Administration is warning people to be on the lookout for counterfeit Ozempic, the diabetes drug that many people use off-label for weight loss.
The federal agency and Novo Nordisk, the Danish pharmaceutical giant that makes Ozempic, said this week that they had learned about "several hundred units" of the drug that made it onto the market outside of the company's approved supply chain.
Business
'You forget to eat': How Ozempic went from diabetes medicine to blockbuster diet drug
Ozempic, made by Novo Nordisk, is part of a class of drugs known as GLP-1 agonists. The drugs are used to treat type 2 diabetes and obesity.
The FDA said it was notified by Novo Nordisk about the counterfeit drugs on April 3 and that it seized the identified products on April 9.
Still, both the agency and the company urged consumers, sellers and medical professionals to double-check their Ozempic on hand. The counterfeit products have both the lot number PAR0362 and a serial number starting with 51746517. The lot number is authentic, but the serial numbers are not, the company said.
The Food and Drug Administration is warning not to distribute, use or sell Ozempic products labeled with lot number PAR0362 and serial number starting with the first eight digits 51746517. The Food and Drug Administration hide caption
toggle caption The Food and Drug AdministrationNovo Nordisk reported six adverse events related to this lot of medication, which included both authentic and counterfeit doses. The adverse events appear to be connected to authentic Ozempic, and the side effects were those you might typically see with the drug, according to a company spokesperson, though they did not detail the specific side effects experienced in these cases.